McDonald's Q3: US slowdown, cost pressures, and strategic shifts hit stock
Weak US sales and consumer pullback Q2 same-store sales rose only 0.8%, driven by higher prices, not more customers. Low-income diners cut back spending, and the value menu upset loyal customers, leading to a revenue miss and a 15% stock drop from its peak.
This shows the core demand problem that dragged the stock down.
Rising costs and permanent inflation Management said flat traffic and inflation are here to stay. Beef costs nearly doubled, and Big Mac prices jumped 23%. These cost pressures squeeze profits and make it harder to attract price-sensitive customers.
Highlights the cost side that pressures margins and consumer demand.
GLP-1 drugs threaten demand The rise of GLP-1 weight-loss drugs poses a structural threat to fast-food demand. As more people use these drugs, they may eat less, which could hurt McDonald's sales over the long term.
Identifies a new long-term demand risk that emerged this quarter.
$8.5B franchisee support plan sparks selloff McDonald's announced an $8.5 billion plan to support franchisees, but the stock sold off. While the plan aims to stabilize the system, investors worry about the cost and what it signals about franchisee health.
Shows a major capital decision that worried investors despite its supportive intent.